Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
QLIFE Aktie jetzt für 0€ handeln | |||||
08:30 | QLife Holding AB: Qlife announces additional product line and progresses two new tests into clinical trials | 59 | GlobeNewswire (Europe) | Qlife, a first mover in clinical-grade home diagnostics, and its partner Hipro Biotechnology are advancing two additional biomarker tests-nt-proBNP and potassium-into clinical trials targeting Congestive... ► Artikel lesen | |
27.08. | QLife Holding AB: QLIFE HOLDING AB, Interim Report Q2, April to June 2025 | 80 | GlobeNewswire (Europe) | Towards a merger with a vision
The full report is attached and can also be found here: https://qlifeholding.com/en/investors/finansiella-rapporter
Financial summary - second quarter 2025
Revenue... ► Artikel lesen | |
27.08. | QLife Holding AB: Progress update on the reverse takeover process between Qlife and Hipro | 89 | GlobeNewswire (Europe) | Gothenburg, Sweden - Qlife Holding AB ("Qlife" or the "Company") and Hipro Biotechnology Co., Ltd. ("Hipro") remain fully committed to completing the transaction announced in the Letter of Intent signed... ► Artikel lesen | |
21.08. | Qlife Holding AB increases existing credit facility and extends the maturity date | 1 | Cision News | ||
21.08. | QLIFE HOLDING AB: Qlife together with Birmingham Women's and Children's NHS Foundation Trust achieve positive results for its rare disease self-test PHE product | 2 | Cision News | ||
09.07. | QLIFE HOLDING AB: Qlife resolves to carry out a directed set-off issue of approximately SEK 2.47 million in accordance with previously announced credit facility agreement | 1 | Cision News | ||
05.06. | Qlife Holding AB receives observation status | 194 | GlobeNewswire | Today, June 5, 2025, Qlife Holding AB (the "Company") issued a press release with information that it has entered into a letter of intent for a reverse takeover of Hipro Biotechnology Co., Ltd.,... ► Artikel lesen | |
05.06. | QLife Holding AB: Qlife enters letter of intent with Hipro Biotechnology Co., Ltd. to join forces through a reverse takeover | 174 | GlobeNewswire (Europe) | Qlife Holding AB ("Qlife" or the "Company") has entered into a non-binding letter of intent ("Letter of Intent") with Hipro Biotechnology Co., Ltd., registration no. 91130100794182204D, ("Hipro") regarding... ► Artikel lesen | |
28.05. | QLife Holding AB: Bulletin from the annual general meeting 2025 of Qlife Holding AB | 112 | GlobeNewswire (Europe) | Qlife Holding AB held its annual general meeting on 28 May 2025. At the meeting, the following resolutions were made.
The English text is an unofficial translation. In case of any discrepancies between... ► Artikel lesen | |
20.05. | QLife Holding AB: QLIFE HOLDING AB, Interim Report Q1, January to March 2025 | 194 | GlobeNewswire (Europe) | Progress on all levels
The full report is attached and can also be found here: https://qlifeholding.com/en/investors/finansiella-rapporter
Financial summary - first quarter 2025
Revenue in the... ► Artikel lesen | |
07.05. | Qlife Holding AB publishes Annual Report for 2024 | 1 | Cision News | ||
10.04. | QLIFE HOLDING AB: Qlife announces strategic roadmap update | 2 | Cision News | ||
25.03. | QLife Holding AB: Qlife announces that it has received approval from UK authorities to initiate a clinical trial in the UK | 183 | GlobeNewswire (Europe) | The Egoo Phe System, developed to measure phenylalanine (Phe) levels associated with the PKU condition, is now entering its final phase ahead of initial registration in the UK and submission to a Notified... ► Artikel lesen | |
21.03. | QLife Holding AB: Bulletin from the extraordinary general meeting in Qlife Holding AB on 21 March 2025 | 237 | GlobeNewswire (Europe) | Today, on 21 March 2025, an extraordinary general meeting was held in Qlife Holding AB. A summary of the adopted resolutions follows below.
Election and remuneration of the board of directors
The... ► Artikel lesen | |
04.03. | The observation status for Qlife Holding AB is removed | 192 | GlobeNewswire | On February 13, 2024, Qlife Holding AB (the "Company") was given observation status with reference to material adverse uncertainty in respect of the issuer's financial position.
On February 26... ► Artikel lesen | |
26.02. | QLife Holding AB: Qlife announces outcome in rights issue | 249 | GlobeNewswire (Europe) | NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA, SINGAPORE, SOUTH AFRICA... ► Artikel lesen | |
17.02. | QLife Holding AB: Qlife announces the launch of Egoo.AI and the start of sales for the Women's Health platform | 280 | GlobeNewswire (Europe) | Qlife is proud to announce a major expansion of Egoo.Health with the launch of Egoo.AI, an advanced AI-driven platform designed to provide users with personalized insights based on biomarker test results... ► Artikel lesen | |
06.02. | QLife Holding AB: QLIFE HOLDING AB, Interim Report Q4, October to December 2024 | 199 | GlobeNewswire (Europe) | Transition to a commercial business
Financial summary - fourth quarter 2024
Revenue in the period amounted to kSEK 50 (30).
EBITDA for the period amounted to kSEK -7,721 (-86,903), and net loss... ► Artikel lesen | |
05.02. | XFRA CAPITAL ADJUSTMENT INFORMATION - 05.02.2025 | 242 | Xetra Newsboard | Das Instrument MI6 AU000000MWY2 MIDWAY LTD EQUITY wird cum Kapitalmassnahme gehandelt am 05.02.2025 und ex Kapitalmassnahme am 06.02.2025 The instrument MI6 AU000000MWY2 MIDWAY LTD EQUITY is traded... ► Artikel lesen | |
31.01. | QLife Holding AB: Qlife comments on the CEO of the company getting a sanction from Finansinspektionen | 180 | GlobeNewswire (Europe) | The CEO of Qlife Thomas Warthoe has been sanctioned by Finansinspektionen related to insider information.
The sanction relates to an incident in February 2023 when Thomas Warthoe forwarded an email... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
MOUNTAIN VALLEY MD | 0,011 | -13,64 % | Mountain Valley MD Holdings Inc: Mountain Valley appoints Batchelor as director | ||
FRESENIUS | 46,860 | +0,69 % | +40 Prozent seit Jahresbeginn: Fresenius kehrt mit Milliarden-Anleihe zurück - Analysten empfehlen zum Kauf! | © Foto: Arne Dedert/dpaFresenius stärkt mit einer Milliarden-Anleihe seine Bilanz und Analysten sehen trotz Rallye weiteres Kurspotenzial für die Aktie.Der Gesundheitskonzern Fresenius ist mit einer... ► Artikel lesen | |
FRESENIUS MEDICAL CARE | 42,060 | -1,04 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
SIEMENS HEALTHINEERS | 47,810 | +0,40 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
GERRESHEIMER | 43,100 | +2,04 % | Evotec, Gerresheimer, Hugo Boss, Lufthansa, Northern Data, SMA Solar - Aktien-Positionen der Short-Seller | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen | |
NANOVIBRONIX | 11,500 | +84,00 % | NanoVibronix stock soars after securing new U.S. patent for medical guidance system | ||
UNITEDHEALTH | 297,35 | -1,18 % | Opening Bell: Robinhood, AppLovin, Enphase Energy, Tesla, UnitedHealth, Echostar, Lululemon, Oracle | Der marktbreite S&P 500 kletterte zwar im frühen Handel auf ein Rekordhoch von 6.532 Punkten, drehte danach jedoch ins Minus und schloss 0,32 Prozent tiefer bei 6.481 Zählern. Auch der Dow Jones konnte... ► Artikel lesen | |
CARL ZEISS MEDITEC | 42,900 | +0,37 % | Carl Zeiss Meditec, HelloFresh, Hensoldt, Lanxess, SMA Solar, Suss MicroTec - Aktien-Positionen der Short-Seller | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen | |
ECKERT & ZIEGLER | 17,270 | +0,58 % | EQS-News: Eckert & Ziegler SE: Berenberg startet Coverage mit "Kauf"-Empfehlung und Kursziel von 24 € - Kurspotenzial 47% | EQS-News: Eckert & Ziegler SE
/ Schlagwort(e): Research Update
Eckert & Ziegler: Berenberg startet Coverage mit "Kauf"-Empfehlung und Kursziel von 24 € - Kurspotenzial 47%
09.09.2025... ► Artikel lesen | |
HIMS & HERS HEALTH | 46,610 | -1,46 % | Hims and Hers stock faces pressure as BofA reiterates Underperform rating | ||
KINDLY MD | 1,310 | -52,71 % | KindlyMD, Inc: KindlyMD Approved for Options Trading on Nasdaq | SALT LAKE CITY, UT / ACCESS Newswire / September 10, 2025 / KindlyMD, Inc. (NASDAQ:NAKA) ("KindlyMD" or "the Company"), a provider of integrated healthcare services and a Bitcoin treasury vehicle via... ► Artikel lesen | |
BRIGHTSPRING HEALTH SERVICES | 26,620 | +0,60 % | BrightSpring Health: UBS bestätigt Kaufempfehlung angesichts starker Wachstumsaussichten | ||
PROCEPT BIOROBOTICS | 39,170 | +5,47 % | PROCEPT BioRobotics Reports Second Quarter 2025 Financial Results and Increases 2025 Revenue Guidance | SAN JOSE, Calif., Aug. 06, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
ALIGNMENT HEALTHCARE | 16,200 | +1,06 % | Alignment Healthcare, Inc. - 8-K, Current Report | ||
INTUITIVE SURGICAL | 370,80 | -3,21 % | ISRG Stock Down More than 13% in 3 Months: How to Play the Stock? |